Director Share Purchase

Arix Bioscience PLC (ARIX)
Director Share Purchase

21-Dec-2020 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

Arix Bioscience plc

LONDON, 21 December 2020: Arix Bioscience plc ("Arix", LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that Naseem Amin, Executive Chairman, purchased 183,000 ordinary shares ("Ordinary Shares") in the Company on 18 December 2020 at a price of 206p per share, via a corporate entity in which he has a majority beneficial interest.

The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the transaction in number of Ordinary Shares.

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Naseem Amin
2	Reason for the notification
a)	Position / status	Executive Chairman
b)	Initial notification / Amendment	Initial Notification
3	Details of issuer
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of Arix Bioscience plc
	Identification code	GB00BD045071
b)	Nature of the transaction	Purchase of Ordinary Shares by Davum Capital Limited, a corporate entity in which Naseem Amin has a majority beneficial interest
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		206.00p	183,000
d)	Aggregated information	Aggregated price	Aggregated volume
		N/A (single transaction)	N/A (single transaction)
e)	Date of the transaction	18 December 2020
f)	Place of the transaction	London Stock Exchange (XLON)